How many institutions held ABUS - Arbutus Biopharma Corp - Common Shares, without par value in Q1 2020?

44 institutional investors reported ABUS - Arbutus Biopharma Corp - Common Shares, without par value for Q1 2020. Use the holders table for investor-level position and value details.

Arbutus Biopharma Corp - Common Shares, without par value (ABUS)

Q: What does CUSIP 03879J100 represent in this 13F holders report?

CUSIP 03879J100 is the security identifier for ABUS - Arbutus Biopharma Corp - Common Shares, without par value used to aggregate holder disclosures.

CUSIP: 03879J100

Q1 2020 13F Holders as of 31 Mar 2020

Security type / class: Equity / Common Shares, without par value
Total 13F shares: 26,281,827
Total 13F value: $26,537,879
Share change: -1,384,525
Put/Call ratio: 1.2%
SEC-reported price per share: $1.01
Number of holders: 44
Value change: -$13,148,563
Number of buys: 25
Number of sells: 27
Shares outstanding: 197,420,670

Security key

03879J100

Report period

Q1 2020

Institutions

Top holders

ABUS full security history Ownership snapshot Full 13F holder table Arbutus Biopharma Corp SEC filings Arbutus Biopharma Corp company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ABUS - Arbutus Biopharma Corp - Common Shares, without par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

RTW INVESTMENTS, LP

Disclosed value leader

RTW INVESTMENTS, LP

Comparable rows

15/15

Latest evidence

31 Dec 2019

13F Lead comparable stake: 2.9% Showing 1-6 of 15 holder rows.

Quick read

RTW INVESTMENTS, LP leads the comparable SEC ownership view at 2.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RTW INVESTMENTS, LP's linked filing trail.

Comparable ownership Top 5

RTW INVESTMENTS, LP 2.9%

Foresite Capital Management IV, LLC 1.9%

JENNISON ASSOCIATES LLC 1.5%

Point72 Asset Management, L.P. 0.96%

MORGAN STANLEY 0.95%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
RTW INVESTMENTS, LP	13F Company 13F	2.9%	$15,754,000 5,666,754 shares	—	31 Dec 2019
Foresite Capital Management IV, LLC	13F Company 13F	1.9%	$10,300,000 3,705,128 shares	—	31 Dec 2019
JENNISON ASSOCIATES LLC	13F Company 13F	1.5%	$8,184,000 2,943,789 shares	—	31 Dec 2019
Point72 Asset Management, L.P.	13F Company 13F	0.96%	$5,274,000 1,897,284 shares	—	31 Dec 2019
MORGAN STANLEY	13F Company 13F	0.95%	$5,202,000 1,871,088 shares	—	31 Dec 2019
LADENBURG THALMANN FINANCIAL SERVICES INC.	13F Company 13F	0.9%	$4,934,000 1,774,815 shares	—	31 Dec 2019

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

26,281,827

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2020 vs Q1 2020 Across Filers

Q1 2020 holders

Holder diff

Investor	Q1 2020 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q1 2020 value	Q1 2020 value	Value change	Value Chg %